Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine.

Funderburg, Nicholas T; Andrade, Adriana; Chan, Ellen S; Rosenkranz, Susan L; Lu, Darlene; Clagett, Brian; Pilch-Cooper, Heather A; Rodriguez, Benigno; Feinberg, Judith; Daar, Eric; Mellors, John; Kuritzkes, Daniel; Jacobson, Jeffrey M; Lederman, Michael M

Funderburg, Nicholas T; Andrade, Adriana; Chan, Ellen S; Rosenkranz, Susan L; Lu, Darlene; Clagett, Brian; Pilch-Cooper, Heather A; Rodriguez, Benigno; Feinberg, Judith; Daar, Eric; Mellors, John; Kuritzkes, Daniel; Jacobson, Jeffrey M; Lederman, Michael M.

Afiliação

Funderburg NT; Case Western Reserve University, Division of Infectious Diseases and HIV Medicine, Cleveland, Ohio, United States of America.
Andrade A; The Johns Hopkins University, Baltimore, Maryland, United States of America.
Chan ES; Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Rosenkranz SL; Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Lu D; Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Clagett B; Case Western Reserve University, Division of Infectious Diseases and HIV Medicine, Cleveland, Ohio, United States of America.
Pilch-Cooper HA; Case Western Reserve University, Division of Infectious Diseases and HIV Medicine, Cleveland, Ohio, United States of America.
Rodriguez B; Case Western Reserve University, Division of Infectious Diseases and HIV Medicine, Cleveland, Ohio, United States of America.
Feinberg J; University of Cincinnati Medical Center, Cincinnati, Ohio, United States of America.
Daar E; Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, California, United States of America.
Mellors J; University of Pittsburg Medical Center, Pittsburg, Pennsylvania, United States of America.
Kuritzkes D; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Jacobson JM; Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America.
Lederman MM; Case Western Reserve University, Division of Infectious Diseases and HIV Medicine, Cleveland, Ohio, United States of America.

PLoS One ; 8(12): e83514, 2013.

Article em En | MEDLINE | ID: mdl-24367599

Assuntos

Fármacos Anti-HIV/farmacologia; Linfócitos T CD4-Positivos/efeitos dos fármacos; Linfócitos T CD4-Positivos/imunologia; Infecções por HIV/tratamento farmacológico; Infecções por HIV/imunologia; HIV-1/efeitos dos fármacos; Ativação Linfocitária/efeitos dos fármacos; Adenina/análogos & derivados; Adenina/farmacologia; Adenina/uso terapêutico; Adulto; Fármacos Anti-HIV/uso terapêutico; Biomarcadores/metabolismo; Contagem de Linfócito CD4; Desoxicitidina/análogos & derivados; Desoxicitidina/farmacologia; Desoxicitidina/uso terapêutico; Emtricitabina; Feminino; Infecções por HIV/sangue; HIV-1/fisiologia; Humanos; Masculino; Pessoa de Meia-Idade; Organofosfonatos/farmacologia; Organofosfonatos/uso terapêutico; Pirrolidinonas/farmacologia; Pirrolidinonas/uso terapêutico; Raltegravir Potássico; Tenofovir; Adulto Jovem

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Ativação Linfocitária / Linfócitos T CD4-Positivos / Infecções por HIV / HIV-1 / Fármacos Anti-HIV Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google